Ellington v. Bilsel

626 N.E.2d 386, 255 Ill. App. 3d 233, 193 Ill. Dec. 353, 1993 Ill. App. LEXIS 2032
CourtAppellate Court of Illinois
DecidedDecember 30, 1993
Docket5-92-0124
StatusPublished
Cited by19 cases

This text of 626 N.E.2d 386 (Ellington v. Bilsel) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ellington v. Bilsel, 626 N.E.2d 386, 255 Ill. App. 3d 233, 193 Ill. Dec. 353, 1993 Ill. App. LEXIS 2032 (Ill. Ct. App. 1993).

Opinion

JUSTICE WELCH

delivered the opinion of the court;

On December 29, 1988, Glenda Ellington (plaintiff), as special administratrix of the estate of Darlene Riddle (decedent), filed suit against Doctor Yilmaz Bilsel (defendant) in the circuit court of St. Clair County pursuant to the Wrongful Death and Survival Acts (Ill. Rev. Stat. 1991, ch. 70, par. 0.01 et seq.; Ill. Rev. Stat. 1991, ch. IIOV2, par. 27 — 6), alleging that the death of the decedent was the result of medical malpractice. Specifically, the plaintiff alleged that the defendant’s prescription of Zarontin and Dilantin (antiseizure medications), either separately or in combination, resulted in the decedent’s development of aplastic anemia (a blood disease), which caused the decedent’s untimely death at the age of 22.

Trial commenced on October 21, 1991, and proceeded through October 29, 1991. The plaintiff called eight witnesses: (1) Dr. Jonathan Borak (an internist, assistant professor of medicine, and medical expert witness from New Haven, Connecticut); (2) Stephen Frost (decedent’s brother); (3) Julie Frost (decedent’s sister); (4) Glenda Ellington (decedent’s mother); (5) Yilmaz Bilsel (defendant); (6) Dr. Ronald Welch (a neurologist); (7) Dr. Leroy Grossman (an economics professor and expert witness); and (8) Dr. Shabir Safdar (a hematologist who treated the decedent). The defendant called three witnesses: (1) Brenda McManame (defendant’s medical assistant and secretary from 1981-84); (2) Yilmaz Bilsel; and (3) Simon Horenstein (a neurologist, professor, and expert medical witness). Counsel for both parties conducted extensive examination of the witnesses.

Briefly stated, the following evidence was adduced at trial. In 1978, the defendant began treating the decedent for, inter alia, a preexisting seizure disorder. In October 1982, the defendant prescribed Zarontin for the decedent. In November 1982, the defendant prescribed Dilantin for the decedent. On June 5, 1983, the decedent was admitted to St. Elizabeth Hospital in Belleville by a Dr. Kahlid. Following unsuccessful treatment, the decedent died on December 21, 1983, as a result of her aplastic anemia. There were essentially two pivotal and highly contested issues at trial: (1) whether there existed a physician-patient relationship between the defendant and the decedent and (2) whether the decedent’s aplastic anemia was caused by Zarontin and Dilantin or whether it was idiopathic (having no known cause). The case went to the jury on October 29, 1991. Later that day, the jury returned a verdict against the plaintiff and in favor of the defendant. On October 30, 1991, the circuit court entered judgment on the verdict.

On November 26, 1991, the plaintiff filed a post-trial motion asking the court to grant a new trial. On- November 27, 1991, the plaintiff filed an amendment to her post-trial motion. On January 24, 1992, the court denied the motion. The plaintiff now appeals and raises the following three issues: (1) whether defense counsel’s closing argument deprived the plaintiff of a fair trial; (2) whether the defendant violated the Dead Man’s Act (Ill. Rev. Stat. 1991, ch. 110, par. 8-201 (now 735 ILCS 5/8-201 (West 1992))) such that the plaintiff was denied a fair trial; and (3) whether the jury was properly instructed. We answer the first two issues in the negative and the third in the affirmative. Consequently, the circuit court is affirmed in all respects.

The first issue concerns statements made by defense counsel during closing argument. The plaintiff contends that defense counsel’s references to Dr. Borak (plaintiff’s expert medical witness) as being “polished” and a “performer” were improper, inflammatory, and prejudicial and denied her a fair trial. In closing argument, defense counsel stated the folio-wing:

“And what did [Dr. Safdar] tell us? He said the subject of where a patient and a doctor’s responsibility in this relationship starts and ends is something that has been debated for a long time in medical circles, that it’s not something that can be decided one way or the other in a situation like this, and that he is not prepared to say that Dr. Bilsel violated it. Who does say it? Dr. Borak says it. Yes, Dr. Borak. He says that— and he’s a very polished witness. He dresses very well. He presents himself very well. He speaks — he’s art — speaks very well, very articulate. He’s obviously a very bright, intelligent man. No wonder that the Intercity Consulting Company sends him out around the country to talk to juries in cases.
You know you need to ask yourself something about a witness that’s that polished that comes to you from New Haven, Connecticut like why? What special qualifications does a witness like that bring to the issues under consideration before you? Is it necessary to go all the way to New Haven, Connecticut for a witness or a performer on the subject of treating seizures and then come back to Belleville with a witness who’s polished but doesn’t treat seizures? Who doesn’t treat aplastic anemia? Who’s never used Zarontin? Just practices. Not involved doing the very thing that he says Dr. Bilsel did wrong, or do we finally get some idea of what Intercity Consulting Corporation means when it sends people around.” (Emphasis added.)

The plaintiff further argues that defense counsel’s reference to a nonexistent handwriting expert during closing argument was intentionally misleading, inflammatory, and prejudicial, and resulted in an unfair trial. Defense counsel stated the following in closing argument:

“Dr. Bilsel was shown *** a whole series of handwritten prescriptions. Only one that was his that’s been shown to him in this case was the one he identified, the one we showed you, and plaintiff asked Dr. Bilsel some questions about those pads. He said, ‘That’s your writing? Is that your signature?’ Dr. Bilsel said no to all that. So the plaintiff’s lawyer must have been challenging him about those things. Well, Dr. Bilsel’s always denied it. They knew he was denying it. Did you see their handwriting expert?
* * *
I heard something in this argument here today about Dr. Popovic and Dr. Kahlid. Well, you’ve seen a performance from a lawyer that’s not overlooking anything, ladies and gentlemen, and you’re entitled to understand that if the plaintiff thought that Dr. Popovic or Dr. Kahlid would have something critical of Dr. Bilsel or help him prove what he needed to prove, do you think they would have left him out of the case? Or the handwriting expert or the people from the pharmacy? No, they didn’t call them either.” (Emphasis added.)

We begin by noting that wide latitude must be afforded counsel in closing argument. (Moore v. Centreville Township Hospital (1993), 246 Ill. App. 3d 579, 590, 616 N.E.2d 1321, 1329; Lewis v. Cotton Belt Route — St. Louis Southwestern Ry. Co. (1991), 217 Ill. App. 3d 94, 119, 576 N.E.2d 918, 937.) We further note that plaintiff failed to make contemporaneous objections to defense counsel’s comments during trial. Plaintiff first objected to the comments in a post-trial motion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cretton v. Protestant Memorial Medical Center, Inc.
864 N.E.2d 288 (Appellate Court of Illinois, 2007)
Manus v. Trans States Airlines, Inc.
835 N.E.2d 70 (Appellate Court of Illinois, 2005)
Thornhill v. Midwest Physician Center
Appellate Court of Illinois, 2003
Profit Management Development, Inc. v. Jacobson, Brandvik & Anderson, Ltd.
721 N.E.2d 826 (Appellate Court of Illinois, 1999)
Pryor v. National Railroad Passenger Corp.
703 N.E.2d 997 (Appellate Court of Illinois, 1998)
Ficken v. Alton & Southern Railway Co.
685 N.E.2d 1 (Appellate Court of Illinois, 1997)
Jacobs v. Union Pacific R.R. Co.
Appellate Court of Illinois, 1997
Jacobs v. Union Pacific Railroad
683 N.E.2d 176 (Appellate Court of Illinois, 1997)
O'Donnell v. Holy Family Hospital
682 N.E.2d 386 (Appellate Court of Illinois, 1997)
O'Connell v. Holy Family Hospital
Appellate Court of Illinois, 1997
State v. Walker
910 S.W.2d 381 (Tennessee Supreme Court, 1995)
Holton v. Memorial Hospital
655 N.E.2d 29 (Appellate Court of Illinois, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
626 N.E.2d 386, 255 Ill. App. 3d 233, 193 Ill. Dec. 353, 1993 Ill. App. LEXIS 2032, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ellington-v-bilsel-illappct-1993.